Israeli Technological progress has brought about many changes in the field of medicine. Methods that in the past were considered science fiction, are now used as an alternative to diagnose diseases without invading the patient's body. For example, the use of robotic surgery was previously considered impossible, but today it is a standard practice in hospitals. This time, a non-invasive way to detect prostate cancer is shaking up the medical community, with some calling the 'liquid biopsy' a game changer in the early diagnosis of cancer.
Similarly, the development of artificial organs and prostheses has revolutionized the way we treat patients. These are just two examples of how science fiction has become a reality in the field of medicine. As for cancer, in the past biopsy was the most common method for diagnosing prostate cancer, however, traditional biopsies that require taking a sample from the organ where the tumor is located are an invasive procedure.
Israel is considered a leader in the field of oncology in general and prostate cancer treatment in particular.— Isotopia Molecular Imaging (@Isotopia_il) February 13, 2023
The largest and most important hospitals in Israel have gained a sterling reputation for providing these treatments, and we are happy to provide and support them. pic.twitter.com/JP0sNo4LaJ
Liquid biopsy is a non-invasive diagnostic technique that involves the analysis of various biomarkers present in body fluids such as blood, urine, and saliva. This technique, which is performed from a simple blood sample, is easy and fast for the patient and has gained significant attention in Israel in recent years due to its potential to detect cancer at an early stage, monitor the progress of the disease and predict the response to treatment.
Wow! A team at Israel's @HebrewU has created a groundbreaking 'liquid biopsy blood test' as an alternative to painful biopsies.— Israeli Culture (@IsraeliCulture) December 18, 2021
Once again, #Israel proves to be a trailblazer in medical technology! 👏💉 pic.twitter.com/oht3EOHTI8
This technique is less invasive than traditional biopsy methods, which require the removal of tissue samples from the body. Liquid biopsy is already revolutionizing the diagnosis and treatment of cancer, and ongoing studies are examining its use in other diseases as well. While blood tests may not completely replace biopsies in all cases, they offer a promising alternative that can save patients time, discomfort, and risk.
In recent months, a non-invasive method for diagnosing prostate cancer entered Israel as part of the advanced category of liquid biopsy. This is a new blood test that makes it possible to detect aggressive prostate cancer with an impressive accuracy rate of about 90%. The revolutionary aspect of the test called IsoPSA lies in the decoding technology, which identifies changes in the structure of the protein extracted from the blood sample that result solely from the development of a cancerous tumor.
Hear from Prof. Nir Peled, a leading medical oncologist from Israel, as he shares his clinical experience of using the Guardant360® liquid biopsy test. pic.twitter.com/A0kRciVhl9— Guardant Health AMEA (@GuardantAMEA) October 21, 2022
As a result, doctors can more reliably determine how likely a patient is to have significant prostate cancer. The test was originally developed as a diagnostic tool developed by researchers at the Cleveland Clinic in the United States but is being heavily invested in by Israeli medical researchers. One of the main advantages of the test is its ability to reduce the number of unnecessary biopsies. Because by using it, doctors can identify which patients have a high risk of prostate cancer and only refer them to a biopsy, and which patients can completely avoid the need for this invasive operation. The test was recently approved by the Israeli Ministry of Health and has already revolutionized the field of prostate cancer diagnosis in Israel.